Reposted by Monica Diteman
American drug companies Merck and Moderna have created a vaccine that has stopped skin cancer returning in patients during a trial. Each vaccine is created specifically for an individual patient by sequencing DNA from patient's tumor and using mRNA to create the vaccine.
bbc.com
Vaccine breakthrough stops cancer returning in trial
A new jab extended the length of time patients were cancer free, but it is unclear for how long.